{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:50:13Z","timestamp":1773215413574,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":1194,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["094417\/Z\/10\/Z"],"award-info":[{"award-number":["094417\/Z\/10\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["GA CR 16\u201307321S"],"award-info":[{"award-number":["GA CR 16\u201307321S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000332","name":"Royal Society of Edinburgh","doi-asserted-by":"publisher","award":["MC_UU_12018\/25"],"award-info":[{"award-number":["MC_UU_12018\/25"]}],"id":[{"id":"10.13039\/501100000332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1074\/mcp.m116.065078","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T20:52:02Z","timestamp":1490302322000},"page":"1138-1150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Quantitative Shotgun Proteomics Unveils Candidate Novel Esophageal Adenocarcinoma (EAC)-specific Proteins"],"prefix":"10.1016","volume":"16","author":[{"given":"J. Robert","family":"O'Neill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Song","family":"Pak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erola","family":"Pairo-Castineira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicki","family":"Save","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Paterson-Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Nenutil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo\u0159ivoj","family":"Vojt\u011b\u0161ek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Overton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Scherl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted R.","family":"Hupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/mcp.M116.065078_bib1","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin"},{"key":"10.1074\/mcp.M116.065078_bib2","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1111\/j.1572-0241.2008.02191.x","article-title":"Continuing rapid increase in esophageal adenocarcinoma in England and Wales","volume":"103","author":"Lepage","year":"2008","journal-title":"Am. J. Gastroenterol"},{"key":"10.1074\/mcp.M116.065078_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnci\/dji024","article-title":"The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence","volume":"97","author":"Pohl","year":"2005","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1074\/mcp.M116.065078_bib4","series-title":"National Oesophago-Gastric Cancer Audit","author":"Groene","year":"2012"},{"key":"10.1074\/mcp.M116.065078_bib5","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1136\/gut.2010.228254","article-title":"Guidelines for the management of oesophageal and gastric cancer","volume":"60","author":"Allum","year":"2011","journal-title":"Gut"},{"key":"10.1074\/mcp.M116.065078_bib6","doi-asserted-by":"crossref","first-page":"e09","DOI":"10.1097\/IJ9.0000000000000009","article-title":"Patients unfit for neoadjuvant therapy may still undergo resection of locally advanced esophageal or esophagogastric junctional cancer with acceptable oncological results","volume":"2","author":"O'Neill","year":"2017","journal-title":"IJS Oncol"},{"key":"10.1074\/mcp.M116.065078_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/bjs.8966","article-title":"Differences in outcomes of oesophageal and gastric cancer surgery across Europe","volume":"100","author":"Dikken","year":"2013","journal-title":"Br. J. Surg"},{"key":"10.1074\/mcp.M116.065078_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/bjs.9968","article-title":"Risk adjustment models for short-term outcomes after surgical resection for oesophagogastric cancer","volume":"103","author":"Fischer","year":"2016","journal-title":"Br. J. Surg"},{"key":"10.1074\/mcp.M116.065078_bib9","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00268-007-9452-1","article-title":"Imaging of primary and metastatic pancreatic cancer using a fluorophore-conjugated anti-CA19\u20139 antibody for surgical navigation","volume":"32","author":"McElroy","year":"2008","journal-title":"World J. Surg"},{"key":"10.1074\/mcp.M116.065078_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/ajpgi.90250.2008","article-title":"Acid, bile, and CDX: the ABCs of making Barrett's metaplasia","volume":"295","author":"Souza","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol"},{"key":"10.1074\/mcp.M116.065078_bib11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/SLA.0b013e31821111b5","article-title":"Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer\/American Joint Cancer Committee staging system","volume":"253","author":"Gertler","year":"2011","journal-title":"Ann. Surg"},{"key":"10.1074\/mcp.M116.065078_bib12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/ng.3013","article-title":"Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis","volume":"46","author":"Weaver","year":"2014","journal-title":"Nat. Genet"},{"key":"10.1074\/mcp.M116.065078_bib13","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"key":"10.1074\/mcp.M116.065078_bib14","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","article-title":"Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy","volume":"17","author":"Rosenberg","year":"2011","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/mcp.M116.065078_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jprot.2013.01.016","article-title":"MALDI profiles of proteins and lipids for the rapid characterisation of upper GI-tract cancers","volume":"80","author":"Singhal","year":"2013","journal-title":"J. Proteomics"},{"key":"10.1074\/mcp.M116.065078_bib16","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1074\/mcp.M112.024919","article-title":"Initial quantitative proteomic map of 28 mouse tissues using the SILAC mouse","volume":"12","author":"Geiger","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M116.065078_bib17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nature13302","article-title":"A draft map of the human proteome","volume":"509","author":"Kim","year":"2014","journal-title":"Nature"},{"key":"10.1074\/mcp.M116.065078_bib18","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/bjs.9145","article-title":"Defining a positive circumferential resection margin in oesophageal cancer and its implications for adjuvant treatment","volume":"100","author":"O'Neill","year":"2013","journal-title":"Br. J. Surg"},{"key":"10.1074\/mcp.M116.065078_bib19","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1074\/mcp.M110.000661","article-title":"A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism","volume":"9","author":"Cai","year":"2010","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M116.065078_bib20","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.009712","article-title":"A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker","volume":"10","author":"Besson","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M116.065078_bib21","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/ijc.23258","article-title":"Alterations in Barrett's-related adenocarcinomas: A proteomic approach","volume":"122","author":"Peng","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1074\/mcp.M116.065078_bib22","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1074\/mcp.M600175-MCP200","article-title":"Comparative proteomics analysis of Barrett metaplasia and esophageal adenocarcinoma using two-dimensional liquid mass mapping","volume":"6","author":"Zhao","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M116.065078_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wi\u0153niewski","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1074\/mcp.M116.065078_bib24","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1021\/ac901854k","article-title":"Isobaric tagging-based selection and quantitation of cerebrospinal fluid tryptic peptides with reporter calibration curves","volume":"82","author":"Dayon","year":"2010","journal-title":"Anal. Chem"},{"key":"10.1074\/mcp.M116.065078_bib25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jprot.2012.12.012","article-title":"EasyProt\u2013an easy-to-use graphical platform for proteomics data analysis","volume":"79","author":"Gluck","year":"2013","journal-title":"J. Proteomics"},{"key":"10.1074\/mcp.M116.065078_bib26","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jprot.2009.10.015","article-title":"Combining low- and high-energy tandem mass spectra for optimized peptide quantification with isobaric tags","volume":"73","author":"Dayon","year":"2010","journal-title":"J. Proteomics"},{"key":"10.1074\/mcp.M116.065078_bib27","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/pmic.200300485","article-title":"OLAV: towards high-throughput tandem mass spectrometry data identification","volume":"3","author":"Colinge","year":"2003","journal-title":"Proteomics"},{"key":"10.1074\/mcp.M116.065078_bib28","doi-asserted-by":"crossref","first-page":"D1063","DOI":"10.1093\/nar\/gks1262","article-title":"The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013","volume":"41","author":"Vizca\u00edno","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/mcp.M116.065078_bib29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3102\/00346543062004429","article-title":"Caution on the use of variance ratio: A comment","volume":"62","author":"Shaffer","year":"1992","journal-title":"Rev. Educational Res"},{"key":"10.1074\/mcp.M116.065078_bib30","series-title":"Introduction to meta-analysis","author":"Borenstein","year":"2009"},{"key":"10.1074\/mcp.M116.065078_bib31","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/beheco\/ark016","article-title":"The unequal variance t-test is an underused alternative to Student's t-test and the Mann-Whitney U test","volume":"17","author":"Ruxton","year":"2006","journal-title":"Behavioural Ecol"},{"key":"10.1074\/mcp.M116.065078_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/00401706.1981.10487680","article-title":"A comparative study of tests for homogeneity of variances, with applications to the outer continental shelf bidding data","volume":"23","author":"Conover","year":"1981","journal-title":"Technometrics"},{"key":"10.1074\/mcp.M116.065078_bib33","first-page":"28","article-title":"The generalization of \u201cStudent's\u201d problem when several different population variances are involved","volume":"34","author":"Welch","year":"1947","journal-title":"Biometrika"},{"key":"10.1074\/mcp.M116.065078_bib34","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1214\/aos\/1013699998","article-title":"The control of the false discovery rate in multiple testing under dependency","volume":"29","author":"Benjamini","year":"2001","journal-title":"Ann. Statistics"},{"key":"10.1074\/mcp.M116.065078_bib35","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1021\/pr4010713","article-title":"Quantitative proteomic profiling of pleomorphic human sarcoma identifies CLIC1 as a dominant pro-oncogenic receptor expressed in diverse sarcoma types","volume":"13","author":"Murray","year":"2014","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.M116.065078_bib36","first-page":"155","article-title":"Prognostic and predictive factors in breast cancer by immunohistochemical analysis","volume":"11","author":"Allred","year":"1998","journal-title":"Mod. Pathol"},{"key":"10.1074\/mcp.M116.065078_bib37","doi-asserted-by":"crossref","first-page":"32384","DOI":"10.1074\/jbc.M109.052647","article-title":"CK1alpha plays a central role in mediating MDM2 control of p53 and E2F-1 protein stability","volume":"284","author":"Huart","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.M116.065078_bib38","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1741-7007-10-90","article-title":"A gene expression atlas of the domestic pig","volume":"10","author":"Freeman","year":"2012","journal-title":"BMC Biol"},{"key":"10.1074\/mcp.M116.065078_bib39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1152\/physiolgenomics.00193.2010","article-title":"Selective gene expression by rat gastric corpus epithelium","volume":"43","author":"Goebel","year":"2011","journal-title":"Physiol. Genomics"},{"key":"10.1074\/mcp.M116.065078_bib40","first-page":"17","article-title":"Reduced expression of cytokeratin 4 and 13 is a valuable marker for histologic grading of esophageal squamous intraepithelial neoplasia","volume":"59","author":"Takashima","year":"2012","journal-title":"J. Med. Dent. Sci"},{"key":"10.1074\/mcp.M116.065078_bib41","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.cell.2011.05.026","article-title":"Residual embryonic cells as precursors of a Barrett's-like metaplasia","volume":"145","author":"Wang","year":"2011","journal-title":"Cell"},{"key":"10.1074\/mcp.M116.065078_bib42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-1-60761-849-2_5","article-title":"Principles and methods of immunohistochemistry","volume":"691","author":"Ramos-Vara","year":"2011","journal-title":"Methods Mol. Biol"},{"key":"10.1074\/mcp.M116.065078_bib43","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.bjc.6690094","article-title":"Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas","volume":"79","author":"Soldes","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1074\/mcp.M116.065078_bib44","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1074\/mcp.M300089-MCP200","volume":"3","author":"Pohler","year":"2004","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M116.065078_bib45","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.humpath.2012.01.004","article-title":"Anterior gradient 2 profiling in Barrett columnar epithelia and adenocarcinoma","volume":"43","author":"Pizzi","year":"2012","journal-title":"Hum. Pathol"},{"key":"10.1074\/mcp.M116.065078_bib46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/bbrc.1998.9440","article-title":"hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines","volume":"251","author":"Thompson","year":"1998","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/mcp.M116.065078_bib47","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1074\/mcp.M500279-MCP200","article-title":"A human protein atlas for normal and cancer tissues based on antibody proteomics","volume":"4","author":"Uhl\u00e9n","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M116.065078_bib48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2407-8-70","article-title":"Expression and clinical significance of glucose regulated proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus","volume":"8","author":"Langer","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1074\/mcp.M116.065078_bib49","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: controlling cell fate decisions under ER stress and beyond","volume":"13","author":"Hetz","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/mcp.M116.065078_bib50","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/onc.2012.346","article-title":"Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development","volume":"32","author":"Chevet","year":"2013","journal-title":"Oncogene"},{"key":"10.1074\/mcp.M116.065078_bib51","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/nm.2964","article-title":"SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells","volume":"18","author":"Baldauf","year":"2012","journal-title":"Nat. Med"},{"key":"10.1074\/mcp.M116.065078_bib52","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1073\/pnas.90.16.7568","article-title":"Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes","volume":"90","author":"Scherle","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1074\/mcp.M116.065078_bib53","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1158\/0008-5472.CAN-08-1397","article-title":"Rho,GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases","volume":"69","author":"Moissoglu","year":"2009","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.M116.065078_bib54","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1158\/1078-0432.CCR-08-2192","article-title":"RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer","volume":"15","author":"Cho","year":"2009","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/mcp.M116.065078_bib55","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.humpath.2003.08.026","article-title":"Frequent EpCam protein expression in human carcinomas","volume":"35","author":"Went","year":"2004","journal-title":"Hum. Pathol"},{"key":"10.1074\/mcp.M116.065078_bib56","first-page":"171","article-title":"Prognostic significance of EpCAM expression in human esophageal cancer","volume":"30","author":"Kimura","year":"2007","journal-title":"Int. J. Oncol"},{"key":"10.1074\/mcp.M116.065078_bib57","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ncb1824","article-title":"Nuclear signalling by tumour-associated antigen EpCAM","volume":"11","author":"Maetzel","year":"2009","journal-title":"Nat. Cell Biol"},{"key":"10.1074\/mcp.M116.065078_bib58","first-page":"49","article-title":"Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors","volume":"27","author":"Rao","year":"2005","journal-title":"Int. J. Oncol"},{"key":"10.1074\/mcp.M116.065078_bib59","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1038\/ncomms4097","article-title":"Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET\/MRI nanoparticle","volume":"5","author":"Thorek","year":"2014","journal-title":"Nat. Commun"},{"key":"10.1074\/mcp.M116.065078_bib60","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1038\/onc.2013.441","article-title":"Context-dependent adaption of EpCAM expression in early systemic esophageal cancer","volume":"33","author":"Driemel","year":"2014","journal-title":"Oncogene"},{"key":"10.1074\/mcp.M116.065078_bib61","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature13438","article-title":"Proteogenomic characterization of human colon and rectal cancer","volume":"513","author":"Zhang","year":"2014","journal-title":"Nature"},{"key":"10.1074\/mcp.M116.065078_bib62","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1021\/pr300411q","article-title":"Addressing statistical biases in nucleotide-derived protein databases for proteogenomic search strategies","volume":"11","author":"Blakeley","year":"2012","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.M116.065078_bib63","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ctrv.2010.03.001","article-title":"Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy","volume":"36","author":"Seimetz","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1074\/mcp.M116.065078_bib64","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1349-7006.2006.00324.x","article-title":"A phase I radioimmunolocalization trial of humanized monoclonal antibody huA33 in patients with gastric carcinoma","volume":"97","author":"Sakamoto","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1074\/mcp.M116.065078_bib65","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1158\/1078-0432.CCR-04-2330","article-title":"Phase I trial of 131I-huA33 in patients with advanced colorectal carcinoma","volume":"11","author":"Chong","year":"2005","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/mcp.M116.065078_bib66","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(15)00483-0","article-title":"TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b\/3 trial","volume":"17","author":"Quoix","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1074\/mcp.M116.065078_bib67","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1200\/JCO.2012.43.7103","article-title":"Adjuvant MAGE-A3 Immunotherapy in Resected Non-Small-Cell Lung Cancer: Phase II Randomized Study Results","volume":"31","author":"Vansteenkiste","year":"2013","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/mcp.M116.065078_bib68","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1002\/elps.200600117","article-title":"Automated integration of monolith-based protein separation with on-plate digestion for mass spectrometric analysis of esophageal adenocarcinoma human epithelial samples","volume":"27","author":"Yoo","year":"2006","journal-title":"Electrophoresis"},{"key":"10.1074\/mcp.M116.065078_bib69","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1158\/1078-0432.CCR-08-0679","article-title":"Protein expression profiling in esophageal adenocarcinoma patients indicates association of heat-shock protein 27 expression and chemotherapy response","volume":"14","author":"Langer","year":"2008","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/mcp.M116.065078_bib70","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/his.12193","article-title":"MALDI imaging on large-scale tissue microarrays identifies molecular features associated with tumour phenotype in oesophageal cancer","volume":"63","author":"Quaas","year":"2013","journal-title":"Histopathology"},{"key":"10.1074\/mcp.M116.065078_bib71","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/path.4199","article-title":"Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria","volume":"230","author":"Aichler","year":"2013","journal-title":"J. Pathol"},{"key":"10.1074\/mcp.M116.065078_bib72","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1016\/j.jprot.2012.02.012","article-title":"MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma","volume":"75","author":"Elsner","year":"2012","journal-title":"J. Proteomics"},{"key":"10.1074\/mcp.M116.065078_bib73","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1442-2050.2005.00488.x","article-title":"Analysis of protein expression patterns in Barrett's esophagus using MALDI mass spectrometry, in search of malignancy biomarkers","volume":"18","author":"Streitz","year":"2005","journal-title":"Dis. Esophagus"}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620323756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620323756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.M116.065078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:35:45Z","timestamp":1761525345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947620323756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1535947620323756"],"URL":"https:\/\/doi.org\/10.1074\/mcp.m116.065078","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative Shotgun Proteomics Unveils Candidate Novel Esophageal Adenocarcinoma (EAC)-specific Proteins","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.M116.065078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}